Literature DB >> 9390690

Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation.

A Altmeyer1, R C Simmons, S Krajewski, J C Reed, G W Bornkamm, S Chen-Kiang.   

Abstract

Cell death in B cell terminal differentiation rapidly follows cell cycle arrest in IL-6 differentiation of EBV-immortalized, IgG-bearing human lymphoblastoid cells in vitro. G1 arrest is now found to coincide with repression of EBNA2 and LMP1, two EBV genes essential for B cell transformation, without activation of the viral lytic cycle. IL-6-differentiated B cells die by apoptosis, as evidenced by increases in Annexin V binding activity, PARP cleavage, and chromatin disorganization. Expression of Mcl-1, a Bcl-2 family member, was specifically induced during IL-6 differentiation and down-regulated during apoptosis. Thus, IL-6 reverses EBV immortalization and activates the terminal differentiation program in IgG-bearing human B lymphoblastoid cells, including regulation of an anti-apoptotic gene to coordinate differentiation, cell cycle arrest, and cell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390690     DOI: 10.1016/s1074-7613(00)80387-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  12 in total

1.  Soluble factors produced by activated CD4+ T cells modulate EBV latency.

Authors:  Noémi Nagy; Mónika Adori; Abu Rasul; Frank Heuts; Daniel Salamon; Dorina Ujvári; Harsha S Madapura; Benjamin Leveau; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells.

Authors:  B Y Chang; K B Conroy; E M Machleder; C A Cartwright
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 3.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

4.  Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP.

Authors:  Hsuan Liu; Hsien-Wei Peng; Yi-Sheng Cheng; Hanna S Yuan; Hsin-Fang Yang-Yen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia.

Authors:  Qilin Feng; Y I Wang; Yingda Yang
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

6.  Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors.

Authors:  Jamieson Bretz; Josefina Garcia; Xiangao Huang; Lin Kang; Yang Zhang; Kai-Michael Toellner; Selina Chen-Kiang
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

7.  IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.

Authors:  Loránd L Kis; Daniel Salamon; Emma K Persson; Noémi Nagy; Ferenc A Scheeren; Hergen Spits; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency.

Authors:  Rachna Chandra; Erika Villanueva; Eleonora Feketova; George W Machiedo; György Haskó; Edwin A Deitch; Zoltán Spolarics
Journal:  J Leukoc Biol       Date:  2008-03-19       Impact factor: 4.962

9.  The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance.

Authors:  Alexey V Gordadze; David Poston; Paul D Ling
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.

Authors:  R K Do; E Hatada; H Lee; M R Tourigny; D Hilbert; S Chen-Kiang
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.